经动脉化疗栓塞联合射频或微波消融治疗肝细胞癌：综述
Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review.
作者信息
Galanakis Nikolaos, Kehagias Elias, Matthaiou Nikolas, Samonakis Dimitrios, Tsetis Dimitrios
机构信息
Interventional Radiology Unit, Department of Radiology, University Hospital of Heraklion, Faculty of Medicine, University of Crete, Heraklion, P.C. 71110, Greece.
Department of Gastroenterology, University Hospital of Heraklion, Faculty of Medicine, University of Crete, Heraklion, P.C. 71110, Greece.
出版信息
Hepat Oncol. 2018 Sep 28;5(2):HEP07. doi: 10.2217/hep-2018-0001. eCollection 2018 Apr.
Abstract
Hepatocellular carcinoma (HCC) is the sixth most common type of malignancy. Several therapies are available for HCC and are determined by stage of presentation, patient clinical status and liver function. Local-regional treatment options, including transcatheter arterial chemoembolization, radiofrequency ablation or microwave ablation, are safe and effective for HCC but are accompanied by limitations. The synergistic effects of combined transcatheter arterial chemoembolization and radiofrequency ablation/microwave ablation may overcome these limitations and improve the therapeutic outcome. The purpose of this article is to review the current literature on these combined therapies and examine their efficacy, safety and influence on the overall and recurrence-free survival in patients with HCC.
摘要
肝细胞癌（HCC）是第六大常见恶性肿瘤类型。HCC有多种治疗方法，具体取决于疾病分期、患者临床状况和肝功能。局部区域治疗方案，包括经动脉化疗栓塞、射频消融或微波消融，对HCC安全有效，但也存在局限性。经动脉化疗栓塞与射频消融/微波消融联合应用的协同效应可能克服这些局限性并改善治疗效果。本文旨在综述有关这些联合治疗的当前文献，并探讨其对HCC患者的疗效、安全性以及对总生存期和无复发生存期的影响。
相似文献
1
Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review.
Hepat Oncol. 2018 Sep 28;5(2):HEP07. doi: 10.2217/hep-2018-0001. eCollection 2018 Apr.
2
Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
J Vasc Interv Radiol. 2015 Mar;26(3):330-41. doi: 10.1016/j.jvir.2014.10.047. Epub 2014 Dec 18.
3
Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study.
Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1198-203. doi: 10.1097/MEG.0000000000000688.
4
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
BMC Cancer. 2014 Nov 19;14:849. doi: 10.1186/1471-2407-14-849.
5
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
J Cancer Res Clin Oncol. 2020 Oct;146(10):2669-2680. doi: 10.1007/s00432-020-03254-2. Epub 2020 May 25.
6
Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Curr Med Res Opin. 2015 Aug;31(8):1553-60. doi: 10.1185/03007995.2015.1058249. Epub 2015 Jul 9.
7
8
Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis.
Korean J Radiol. 2016 Jan-Feb;17(1):93-102. doi: 10.3348/kjr.2016.17.1.93. Epub 2016 Jan 6.
9
Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.
Scand J Gastroenterol. 2018 Dec;53(12):1575-1583. doi: 10.1080/00365521.2018.1548645. Epub 2018 Dec 21.
10
Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
Radiology. 2009 Sep;252(3):905-13. doi: 10.1148/radiol.2523081676. Epub 2009 Jun 30.
引用本文的文献
1
Recent Advances in Ablative Therapies for HCC.
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102592. doi: 10.1016/j.jceh.2025.102592. Epub 2025 May 17.
2
Meta-analysis of transarterial chemoembolization combined with cryoablation transarterial chemoembolization alone for ≥ 5 cm hepatocellular carcinoma.
World J Gastrointest Oncol. 2024 Jun 15;16(6):2793-2803. doi: 10.4251/wjgo.v16.i6.2793.
3
In Vivo Thermal Ablation of Deep Intrahepatic Targets Using a Super-Convergent MRgHIFU Applicator and a Pseudo-Tumor Model.
Cancers (Basel). 2023 Aug 3;15(15):3961. doi: 10.3390/cancers15153961.
4
Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors.
Biology (Basel). 2023 Jul 13;12(7):999. doi: 10.3390/biology12070999.
5
Ablative strategies for recurrent hepatocellular carcinoma.
World J Hepatol. 2023 Apr 27;15(4):515-524. doi: 10.4254/wjh.v15.i4.515.
6
Bench-to-bedside development of multifunctional flexible embolic agents.
Theranostics. 2023 Apr 1;13(7):2114-2139. doi: 10.7150/thno.80213. eCollection 2023.
7
Salvage locoregional therapies for recurrent hepatocellular carcinoma.
World J Gastroenterol. 2023 Jan 21;29(3):413-424. doi: 10.3748/wjg.v29.i3.413.
8
Immune checkpoint inhibitor therapy for hepatocellular carcinoma.
Ann Gastroenterol. 2022 Nov-Dec;35(6):568-576. doi: 10.20524/aog.2022.0746. Epub 2022 Oct 3.
9
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis.
Cancer Med. 2021 Dec;10(23):8432-8450. doi: 10.1002/cam4.4350. Epub 2021 Oct 16.
10
Clinical Study on Effect of Solution Focused Approach on the Complications, Pain, Sleep, and Quality of Life in Patients with Hepatocellular Carcinoma Undergoing TACE.
Evid Based Complement Alternat Med. 2021 Sep 15;2021:5068228. doi: 10.1155/2021/5068228. eCollection 2021.
本文引用的文献
1
Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma.
J Cancer Res Ther. 2016 Dec;12(Supplement):C217-C220. doi: 10.4103/0973-1482.200598.
2
Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines.
Radiat Oncol J. 2016 Sep;34(3):160-167. doi: 10.3857/roj.2016.01970. Epub 2016 Sep 28.
3
Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients.
Sci Rep. 2016 Sep 13;6:32728. doi: 10.1038/srep32728.
4
Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Medicine (Baltimore). 2016 May;95(20):e3754. doi: 10.1097/MD.0000000000003754.
5
Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
Cardiovasc Intervent Radiol. 2016 Jul;39(7):1015-22. doi: 10.1007/s00270-016-1314-5. Epub 2016 Mar 14.
6
Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis.
Korean J Radiol. 2016 Jan-Feb;17(1):93-102. doi: 10.3348/kjr.2016.17.1.93. Epub 2016 Jan 6.
7
Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):309-314. doi: 10.1016/j.clinre.2015.07.008. Epub 2015 Oct 1.
8
Guide for diagnosis and treatment of hepatocellular carcinoma.
World J Hepatol. 2015 Jun 28;7(12):1632-51. doi: 10.4254/wjh.v7.i12.1632.
9
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.
World J Hepatol. 2015 May 18;7(8):1054-63. doi: 10.4254/wjh.v7.i8.1054.
10
Hepatocellular carcinoma: From diagnosis to treatment.
World J Hepatol. 2015 May 18;7(8):1020-9. doi: 10.4254/wjh.v7.i8.1020.
Zotero 插件